Eine lange Liste von internationalen Publikationen zeugt von jahrzehntelanger Forschungstätigkeit auf mehreren Gebieten der Neurologie. Bei der klinisch-wissenschaftlichen Forschung und Publikation hatte die Unabhängigkeit von der Industrie für mich von Anfang an und bis zum heutigen Tag oberste Priorität.
2018
Month-of-birth-effect in multiple sclerosis in Austria
Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.
Mult Scler. 2018; [ahead of Print]
Secondary dementia due to Lyme neuroborreliosis
Kristoferitsch W, Aboulenein-Djamshidian F, Jecel J, Rauschka H, Rainer M, Stanek G, Fischer P.
Wien Klin Wochenschr. 2018; 15-16: 468-478
2016
Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders
Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M.
J Neuroinflammation 2016 Jul 1; 13: 176
2015
CROP - The Clinico-Radiologico-Ophthalmological Paradox in Multiple Sclerosis: Are Patterns of Retinal and MRI Changes Heterogeneous and Thus Not Predictable?
Aboulenein-Djamshidian F, Krššák M, Serbecic N, Rauschka H, Beutelspacher S, Kukurová IJ, Valkovič L, Khan A, Prayer D, Kristoferitsch W
PLoS One 2015; 10: e0142272
Antibodies to aquaporin-1 are not present in neuromyelitis optica
Schanda K, Waters P, Holzer H, Aboulenein-Djamshidian F, Leite MI, Palace J, Vukusic S, Marignier R, Berger T, Reindl M
Neurol Neuroimmunol Neuroinflamm 2015; 2: e160
NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases
Ramberger M, Bsteh G, Schanda K, Höftberger R, Rostásy K, Baumann M, Aboulenein-Djamshidian F, Lutterotti A, Deisenhammer F, Berger T, Reindl M
Neurol Neuroimmunol Neuroinflamm 2015; 2: e141
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study
Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian F, Krugluger W, Deisenhammer F, Senel M, Tumani H, Hegen H
Mult Scler. 2015 Jul 21
Reduction in serum aquaporin-4 antibody titers during development of a tumor-like brain lesion in a patient with neuromyelitis optica: a serum antibody-consuming effect?
Aboulenein-Djamshidian F, Höftberger R, Waters P, Krampla W, Lassmann H, Budka H, Vincent A, Kristoferitsch W
J Neuropathol Exp Neurol 2015; 74: 194-197
A case of variably protease-sensitive prionopathy treated with doxycyclin
Assar H, Topakian R, Weis S, Rahimi J, Trenkler J, Höftberger R, Aboulenein-Djamshidian F, Ströbel T, Budka H, Yull H, Head MW, Ironside JW, Kovacs GG
J Neurology Neurosurg Psychiatry 2015; 86: 816-8
2014
Detection of retinal nerve fiber layer defects in Alzheimer‘s disease using SD-OCT
Kromer R, Serbecic N, Hausner L, Aboul-Enein F, Froelich L, Beutelspacher SC
Frontiers in Psychiatry 2014; 5:22
High-resolution spectral domain-optical coherence tomography in multiple sclerosis, Part II – the total macular volume. The first follow-up study over 2 years.
Serbecic N, Aboul-Enein F*, Beutelspacher SC, Khan A, Vass C, Kristoferitsch W, Reitner A, Schmidt-Erfurth U
(*) equal contribution
Frontiers in Neurology 2014; 5:20
2013
Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people
Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.
PLoS One 2013; 8: e79649
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays
Höftberger R, Sabater L, Marignier R, Aboul-Enein F, Bernard-Valnet R, Rauschka H, Ruiz A, Blanco Y, Graus F,
Dalmau J, Saiz A.
PLoS One 2013; 8: e79083
Natalizumab therapy for highly active pediatric multiple sclerosis
Kornek B, Aboul-Enein F, Rostasy K, Milos RI, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Storm van's Gravesande K, Karenfort M, Blaschek A, Meyer A, Seidl R, Debelic D, Vass K, Prayer D, Kristoferitsch W, Bayas A.
JAMA Neurol 2013 70: 469-475
2011
Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M.
J Neuroinflammation 2011 28; 8:184
High Resolution Spectral Domain Optical Coherence Tomography (SD-OCT) in Multiple Sclerosis: The First Follow Up Study over Two Years
Serbecic N, Aboul-Enein F*, Beutelspacher SC, Vass C, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U.
PLoS One 2011; 6: e19843
equal contribution(*)
Reproducibility of high-resolution optical coherence tomography measurements of the nerve fibre layer with the new Heidelberg Spectralis optical coherence tomography
Serbecic N, Beutelspacher SC, Aboul-Enein F, Kircher K, Reitner A, Schmidt-Erfurth U
Br J Ophthalmol 2011; 95: 804-810
2010
Vascular endothelial growth factor: the major factor for tumor neovascularization and edema formation in meningioma patients
Schmid S, Aboul-Enein F*, Pfisterer W, Birkner T, Stadek C, Knosp E.
equal contribution(*)
Neurosurgery, 2010; 67: 1703-1708
Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations
Serbecic N, Aboul-Enein F*, Beutelspacher SC, Graf M, Kircher K, Geitzenauer W, Brannath W, Lang P, Kristoferitsch W, Lassmann H, Reitner A, Schmidt-Erfurth U
(*) equal contribution
PLoS One. 2010; 8: 5(11): e13877
Peroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and betaendorphin
Höftberger R, Kunze M, Voigtländer T, Unterberger U, Regelsberger G, Bauer J, Aboul-Enein F, Garzuly F, Forss-Petter S, Bernheimer H, Berger J, Budka H
Endocrinology 2010; 151: 4801-4810
Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligodendroglial changes in multiple sclerosis
Höftberger R, Fink S, Aboul-Enein F, Botond G, Olah J, Berki T, Ovadi J, Lassmann H, Budka H, Kovacs GG
Glia 2010; 58: 1847-1857
Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla
Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W
PLoS One 2010; 20: 5(7):e11625
Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica
Mader S, Lutterotti A, Di Pauli F, Kuenz B, Schanda K, Aboul-Enein F, Khalil M, Storch MK, Jarius S, Kristoferitsch W, Berger T, Reindl M
PLoS One. 2010; 5:e10455
Diffuse white matter damage is absent in neuromyelitis optica
Aboul-Enein F, Krssák M, Höftberger R, Prayer D, Kristoferitsch W
AJNR 2010; 31: 76-79
2009
Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells
Serbecic N, Lahdou I, Scheuerle A, Höftberger R, Aboul-Enein F
Mol Vis 2009; 15:1312-24
Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study
Krampla W, Aboul-Enein F, Jecel J, Lang W, Fertl E, Hruby W, Kristoferitsch W
Eur Radiol. 2009; 19: 2535-2543
Normal pressure hydrocephalus or neuroborreliosis?
Aboul-Enein F, Kristoferitsch W
Wien Med Wochenschr 2009; 159: 58-61
2008
Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
Jarius S, Aboul-Enein F, Waters P, Kuenz B, Hauser A, Berger T, Lang W, Reindl M, Vincent A, Kristoferitsch W
Brain 2008; 131: 3072-3080
Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-I analysis of grades I and II meningioma tissue
Pfisterer WK, Coons SW, Aboul-Enein F, Hendricks WP, Scheck AC, Preul MC
J Neurooncol 2008; 87: 43-50
Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome
Aboul-Enein F, Höftberger R, Buxhofer-Ausch V, Drlicek M, Lassmann H, Budka H, Kristoferitsch W
Neuropathol Appl Neurobiol 2008; 34: 248-252
2007
Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy
Höftberger R, Kunze M, Weinhofer I, Aboul-Enein F, Voigtländer T, Oezen I, Amann G, Bernheimer H, Budka H, Berger J
Neurobiol Dis 2007; 28: 165-174
Acute cerebral white matter damage in lethal salicylate intoxication
Rauschka H, Aboul-Enein F*, Bauer J, Nobis H, Lassmann H, Schmidbauer M
equal contribution (*)
Neurotoxicology. 2007; 28: 33-37
Continuous intraventricular pressure monitoring for diagnosis of normal-pressure hydrocephalus
Pfisterer WK, Aboul-Enein F, Gebhart E, Graf M, Aichholzer M, Mühlbauer M
Acta Neurochir 2007; 149: 983-990
2006
Late-onset metachromatic leukodystrophy: Genotype strongly influences phenotype
Rauschka H, Colsch B, Baumann N, Wevers R, Schmidbauer M, Krammer M, Turpin JC, Lefevre M, Olivier C, Tardieu S, Krivit W, Moser H, Moser A, Gieselmann V, Zalc B, Cox T, Reuner U, Tylki-Szymanska A, Aboul-Enein F, LeGuern E, Bernheimer H, Berger J
Neurology 2006; 67: 859-63
Advanced Intercross Line Mapping of Eae5 Reveals Ncf-1 and CLDN4 as Candidate Genes for Experimental Autoimmune Encephalomyelitis
Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, Olsson T
J Immunol 2006; 176: 6055-64
Transient Axonal Injury in the Absence of Demyelination: A Correlate of Clinical Disease in Acute Experimental Autoimmune Encephalomyelitis
Aboul-Enein F, Weiser P, Höftberger R, Lassmann H, Bradl M
Acta Neuropathol 2006; 111: 539-47
2005
Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease?
Aboul-Enein F, Lassmann H
Acta Neuropathol 2005;109: 49-55
2004
Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation
Aboul-Enein F, Bauer J, Klein M, Schubart A, Flügel A, Ritter T, Kawakami N, Siedler F, Linington C, Wekerle H, Lassmann H, Bradl M
J Neuropathol Exp Neurol 2004; 63: 1284-96
Comparison of myelin, axon, lipid, and immunopathology in the central nervous system of differentially myelin-compromised mutant mice: a morphological and biochemical study
Loers G, Aboul-Enein F*, Bartsch U, Lassmann H, Schachner M
equal contribution (*)
Mol Cell Neurosci 2004; 27: 175-89
Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions
Höftberger R, Aboul-Enein F*, Brück W, Lucchinetti C, Rodriguez M, Schmidbauer M, Jellinger K, Lassmann H
equal contribution (*)
Brain Pathol 2004; 14: 43-50
2003
CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis
Carboni S, Aboul-Enein F, Waltzinger C, Killeen N, Lassmann H, Pena-Rossi C
J Neuroimmunol 2003; 145: 1-11
Paradoxical effects of arthritis-regulating chromosome 4 regions on myelin oligodendrocyte glycoprotein-induced encephalomyelitis in congenic rats
Becanovic K, Backdahl L, Wallstrom E, Aboul-Enein F, Lassmann H, Olsson T, Lorentzen JC
Eur J Immunol 2003; 33: 1907-16
A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions
Lassmann H, Reindl M, Rauschka H, Berger J, Aboul-Enein F, Berger T, Zurbriggen A, Lutterotti A, Bruck W, Weber JR, Ullrich R, Schmidbauer M, Jellinger K, Vandevelde M
Brain 2003; 126: 1347-57
Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases
Aboul-Enein F*, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, Lucchinetti C, Schmidbauer M, Jellinger K, Lassmann H
equal contribution (*)
J Neuropathol Exp Neurol 2003; 62: 25-33
Deutschsprachige Publikationen
Das Will Rogers Phänomen in der Multiplen Sklerose
Aboul-Enein F
CliniCum neuropsy. 2012; 5: 38-42
Anmerkungen zum “publication bias”
Aboul-Enein F
Neurologisch. 2011; 3: 52-53
Hochauflösende SD-OCT bei MS – erste Verlaufsstudie über 2 Jahre
Aboul-Enein F
Neurologisch. 2011; 3: 54-60
OCT revisited. Korreliert die Retinaschichtdicke mit dem Hirngewicht. Ein kurzer Einblick
Aboul-Enein F
Neurologisch. 2011; 1: 32-35
Komplikationen neuer MS-Therapien: Infektionsprophylaxe und Infektionen
Aboul-Enein F
Neurologisch. 2011; S3: 18-21
Monoklonale Antikörper in der Therapie der Multiplen Sklerose
Aboul-Enein F
Journal für Neurologie, Neurochirurgie und Psychiatrie. 2010; 11: 24-29
Neuromyelitis Optica (NMO) – erste Studie zur epidemiologischen Erfassung der NMO in Österreich
Aboul-Enein F
Neurologisch. 2010; 4: 78-81
Neuromyelitis optica: Klinisches Syndrom, Sonderform der Multiplen Sklerose oder Krankheitsentität?
Aboul-Enein F, Kristoferitsch K
Journal für Neurologie, Neurochirurgie und Psychiatrie. 2006; 7: 21-27
Comments, letters to the editor etc.
Aboul-Enein F, Kristoferitsch W.
Discrepancy of data? (comment to J Neurol Neurosurg Psychiatry 2010;81:409-411 doi:10.1136/jnnp.2008.168070)
JNNP. recent e-Letters; published 23 June 2010.
Aboul-Enein F.
Comment on the article entitled ‘Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis’ by Reuter F, Zaaraoui W, Crespy L, Faivre A, Rico A, Malikova I, Soulier E, Viout P, Ranjeva JP, Pelletier J, Audoin B. (comment to J Neurol Neurosurg Psychiatry 2010; doi:10.1136/jnnp.2010.213744)
JNNP. recent e-Letters; published 12 January 2011.
Aboul-Enein F.
Comment on "Global N-Acetylaspartate Declines Even in Benign Multiple Sclerosis" AJNR Am
J Neuroradiol. 2011 Apr 28.
Aboulenein-Djamshidian F, Serbecic N, Kristoferitsch W.
Optical coherence tomography in multiple sclerosis.
Lancet Neurol. 2016 May;15(6):537-8
Aboulenein-Djamshidian F, Serbecic N, Kristoferitsch W.
Optical coherence tomography in multiple sclerosis.
Lancet Neurol. 2016 May;15(6):537-8